Juno joint venture seeks IPO haul to bring CAR-Ts to China

Juno joint venture seeks IPO haul to bring CAR-Ts to China

Source: 
Fierce Biotech
snippet: 

JW Therapeutics has filed the paperwork (PDF) for a Hong Kong IPO. The Juno Therapeutics-WuXi AppTech joint venture is seeking money to advance a cell therapy pipeline led by anti-CD19 CAR-T JWCAR029.